Key Takeaways & Executive Findings
- •• • MNC inhalation achieved efficient lung deposition and sustained methane release in a bleomycin-induced pulmonary fibrosis model, significantly reducing inflammation and fibrosis while improving lung function without systemic side effects (Jin et al., 2026). • • The acid-responsive methane prodrug Fe(BPY)2(CH3)2 enables spatiotemporally controlled methane release in acidic inflammatory niches, facilitating mucosal penetration and sustained release (Jin et al., 2026). • • MNC rebalances macrophage polarization by inhibiting M2 phenotype overexpression and downregulates the MMP9/TIMP-1 ratio, suppressing myofibroblast proliferation and EMT (Jin et al., 2026). • • The nanocapsule is formulated from biodegradable PLGA-PEG copolymer, ensuring biocompatibility and potential for clinical translation in inhalable gas therapy (Jin et al., 2026).
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease with high mortality and limited therapeutic options. Dysregulated macrophage polarization drives fibroblast activation and epithelial-mesenchymal transition (EMT), yet no effective management exists. Here, we develop an inhalable methane nanocapsule (MNC) that spatiotemporally controls methane release in the lung to remodel the fibrogenic microenvironment. MNC is formulated via self-assembly of biodegradable poly(lactic-co-glycolic acid)-polyethylene glycol (PLGA-PEG) and a novel acid-responsive methane prodrug Fe(BPY)2(CH3)2, enhancing mucosal penetration and sustained methane release in acidic inflammatory niches. In a bleomycin (BLM)-induced pulmonary fibrosis model, MNC inhalation achieves efficient lung deposition and sustained methane release, significantly reducing inflammation, ameliorating fibrosis, and improving lung function without systemic side effects. Mechanistically, MNC rebalances macrophage polarization by inhibiting M2 phenotype overexpression and downregulates the MMP9/TIMP-1 ratio to suppress myofibroblast proliferation and EMT, synergistically halting fibrotic progression. This inhalable methane nanocapsule offers a promising strategy for safe and effective IPF treatment.
1. Introduction
Idiopathic pulmonary fibrosis (IPF) remains a fatal interstitial lung disease with a median survival of 2–4 years post-diagnosis, yet only two anti-fibrotic drugs—Nintedanib and Pirfenidone—are approved, and they merely stall progression while causing adverse effects. The disease is driven by recurrent alveolar epithelial micro-injuries that trigger aberrant epithelial-fibroblast communication, leading to myofibroblast accumulation and excessive extracellular matrix deposition. Chronic profibrotic M2 macrophage polarization amplifies this cascade, but no clinically available therapy effectively reprograms these immune cells. Gasotransmitters, such as methane, offer dual immunomodulatory and anti-fibrotic potential, but their therapeutic application has been hampered by the lack of targeted, inhalable delivery systems that can release gas locally in the diseased lung microenvironment.
This study addresses this bottleneck by engineering an inhalable methane nanocapsule (MNC) that leverages an acid-responsive methane prodrug, Fe(BPY)2(CH3)2, encapsulated within a biodegradable PLGA-PEG matrix. The nanocapsule is designed to penetrate mucosal barriers and release methane sustainedly in the acidic inflammatory niche characteristic of IPF. In a bleomycin-induced pulmonary fibrosis model, MNC inhalation demonstrates efficient lung deposition and therapeutic efficacy, significantly reducing inflammation and fibrosis while improving lung function. Mechanistically, MNC rebalances macrophage polarization and downregulates the MMP9/TIMP-1 ratio, thereby suppressing myofibroblast activation and EMT. This approach offers a promising strategy for safe and effective IPF treatment by remodeling the fibrogenic microenvironment.
Loading authentic research manuscript (Pages 1–5)...
Zhaokui Jin, Xiaoyu Li, Qi Gao, Hantao Wu, Purushothaman Bargavi, Chao Xia, Qianjun He (2026). Inhalable Acid-Responsive Methane Nanocapsule for Remodeling Fibrogenic Microenvironment to Alleviate Idiopathic Pulmonary Fibrosis. SCIENCE CHINA Materials. https://doi.org/10.1007/s40843-025-3679-8
Research & Educational Purpose Only: The translations, structured abstracts, analytical annotations, and data reports provided by SinoGreenTechare intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoGreenTech claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the acid-responsive release mechanism of the methane prodrug Fe(BPY)2(CH3)2, and how does it ensure sustained methane release in the acidic inflammatory niche?
The prodrug Fe(BPY)2(CH3)2 is designed to be stable at physiological pH but undergoes acid-triggered decomposition in the acidic microenvironment (pH ~6.5-7.0) typical of inflamed fibrotic tissue, releasing methane gas. The PLGA-PEG encapsulation further modulates the release kinetics, providing sustained release over an extended period, as evidenced by efficient lung deposition and prolonged therapeutic effects in the bleomycin-induced fibrosis model.
How does MNC inhalation achieve efficient lung deposition and what is the evidence for its therapeutic efficacy in the bleomycin-induced pulmonary fibrosis model?
MNC inhalation leverages aerosol delivery, which facilitates deep lung deposition due to the nanosize and PEGylation that enhances mucosal penetration. In the BLM model, MNC inhalation significantly reduced inflammation and fibrosis, as measured by histology and lung function tests, without systemic side effects. The study reports downregulation of M2 macrophage markers and MMP9/TIMP-1 ratio, indicating effective remodeling of the fibrogenic microenvironment.
What are the potential scalability and manufacturing challenges for clinical translation of this inhalable methane nanocapsule?
Scalability would require reproducible synthesis of the prodrug and nanocapsule formulation, ensuring batch-to-batch consistency in size, drug loading, and release profiles. The use of biodegradable PLGA-PEG is well-established for clinical use, but the novel prodrug requires GMP-compliant manufacturing. Additionally, aerosol delivery devices must be optimized for efficient lung deposition in patients with compromised lung function. Further studies are needed to assess long-term stability and storage conditions.
How does MNC compare with existing anti-fibrotic drugs like Nintedanib and Pirfenidone in terms of efficacy and safety?
While Nintedanib and Pirfenidone only slow disease progression and have side effects, MNC inhalation in the BLM model not only halted fibrosis but also improved lung function, with no systemic toxicity observed. The targeted delivery via inhalation minimizes systemic exposure, potentially reducing adverse effects. However, head-to-head comparative studies and long-term safety evaluations are required to establish superiority in clinical settings.
What is the mechanistic basis for MNC's effect on macrophage polarization and the MMP9/TIMP-1 ratio?
MNC releases methane, which is known to have anti-inflammatory and anti-fibrotic properties. Methane likely modulates macrophage polarization by inhibiting M2 phenotype overexpression, as evidenced by reduced expression of M2 markers. Additionally, methane downregulates the MMP9/TIMP-1 ratio, which is critical for ECM remodeling; an imbalance favors fibrosis. By restoring this ratio, MNC suppresses myofibroblast proliferation and EMT, thereby halting fibrotic progression.
Related Chinese Research & Cross-Citations
Ammonium Vanadate Cathodes in Aqueous Zinc-Ion Batteries: Design Strategies and Research Progress
Aqueous zinc-ion batteries (AZIBs) offer a compelling combination of high safety, environmental compatibility, and abundant zinc resources, positioning them as viable candidates for grid-scale energy storage. Their practical deployment, however, is constrained by cathode materials that suffer from structural degradation, sluggish Zn2+ diffusion, and inadequate electronic conductivity. Ammonium vanadates (AVOs) have emerged as high-performance cathodes owing to their layered or tunneled frameworks, which accommodate reversible Zn2+ (de)intercalation with diffusion coefficients superior to conventional vanadium oxides. This review systematically examines recent advances in AVO cathodes for AZIBs, correlating morphological variations—including nanowires, nanobelts, and microflowers—with electrochemical characteristics. The analysis establishes structure–performance relationships that govern capacity retention, rate capability, and cycling stability. Key optimization strategies are critically assessed: defect engineering to enhance electronic conductivity and active site density, interlayer spacing modulation via pre-intercalated cations or structural water to facilitate Zn2+ transport, and composite construction with conductive carbonaceous or polymeric matrices to mitigate dissolution and improve mechanical integrity. Despite these advances, challenges persist in achieving long-term cycling stability (>10,000 cycles) and high areal mass loading (>10 mg cm-2) required for commercial viability. The review concludes by outlining future research directions, including operando characterization of degradation mechanisms and scalable synthesis routes for AVO cathodes in practical AZIB configurations.
Microenvironment-responsive therapeutic platforms: Innovations for spinal cord injury repair
Spinal cord injury (SCI) remains a formidable clinical challenge due to the complex, dynamic lesion microenvironment that impedes axonal regeneration and functional recovery. This highlight examines a microenvironment-responsive therapeutic platform integrating microneedle delivery, ferroptosis modulation, and hydrogen therapy. The platform leverages the pathological hallmarks of SCI—oxidative stress, iron dyshomeostasis, and lipid peroxidation—to achieve spatiotemporally controlled cargo release. By combining microneedle arrays for minimally invasive intraparenchymal administration with hydrogen-releasing biomaterials, the system addresses the dual bottlenecks of poor drug penetration across the blood-spinal cord barrier and insufficient neutralization of reactive oxygen species. Ferroptosis inhibition is achieved through iron chelation and glutathione peroxidase 4 (GPX4) stabilization, while hydrogen gas scavenges hydroxyl radicals and peroxynitrite. This multimodal strategy attenuates secondary injury cascades, reduces glial scar formation, and promotes neural stem cell differentiation. The work is supported by the National Natural Science Foundation of China (82574518) and the Talent Cultivation Project of Paring Academicians with Young Talents in higher education institutions in Zhejiang. The authors declare no conflict of interest. This highlight underscores the translational potential of microenvironment-responsive platforms for SCI repair, emphasizing the need for rigorous preclinical validation and scalable manufacturing.
Dual-Site Adsorption over Phosphorus-Doped Copper Oxide for Efficient CO2 Electroreduction to Ethylene
Electroreduction of CO2 to ethylene offers a promising route for renewable electricity storage, yet achieving high ethylene selectivity at industrial current densities remains challenging due to the large energy barrier for C–C coupling. Here, we report a “MOF-assisted in situ doping” strategy to introduce the oxophilic nonmetal phosphorus (P) into the copper oxide (CuO) lattice, constructing a localized Cu–P dual-site adsorption configuration for the key *OCCHO intermediate. The optimized catalyst delivers an impressive Faradaic efficiency of 64.6% for ethylene with a partial current density of 646 mA cm-2. Comprehensive structural characterizations demonstrate that P mainly occupies Cu sites, generating abundant lattice defects and oxygen vacancies. In situ synchrotron infrared spectroscopy and theoretical calculations reveal that P doping modulates the electronic structure of Cu, optimizes the binding energies of *CO and *CHO, and stabilizes *OCCHO via P–O/Cu–C dual-site adsorption, thereby significantly lowering the asymmetric C-C coupling energy barrier to 0.74 eV. This work highlights a dual-site microenvironment regulation strategy for CO2-to-ethylene electroreduction.
Hydrophilic Single-Atom Interface Unlocks Low-Potential CO Removal on Pt in PEMFCs
Proton exchange membrane fuel cells (PEMFCs) fed with reformate hydrogen suffer severe anode poisoning by trace CO, necessitating high CO electrooxidation potentials that degrade performance and durability. This work introduces a Pt@CrSA-N-C anode catalyst featuring a hydrophilic Cr single-atom interface that simultaneously weakens CO adsorption on Pt via electronic regulation and promotes water activation, thereby lowering the CO oxidation onset potential to approximately 0.13 V vs. RHE. The onset potential was determined by two independent methods: the first potential at which the background-corrected current exceeds 0 mA cm-2 during CO oxidation reaction tests in a three-electrode system, and the potential at which the forward scan current exceeds the N2 background current in CO-stripping voltammetry. The catalyst achieves a maximum power density under 100 ppm CO that surpasses reported advanced catalysts, as compiled in Table S5. Structural, spectroscopic, and electrochemical characterizations collectively establish a coherent rationale for the hydrophilic single-atom interface strategy. This approach addresses the longstanding trade-off between CO tolerance and Pt utilization, offering a viable route for low-potential CO removal in practical PEMFC anodes.
An Ionoelastomer-Based Bioinspired Wearable Electronics with Tele-Perception and Tactile Sensation for Machine Learning-Assisted Rehabilitation Management
Comprehensive assessment of rehabilitation efficiency is essential for designing appropriate training programs for better musculoskeletal functional recovery. Existing contact-receptor-dependent rehabilitation assessment systems mostly focus on assessing the restoration of muscle function by evaluating grip strength or joint flexion angle; however, parameters reflecting neuromuscular synergistic function are always overlooked. Herein, we develop an ionoelastomer-based soft artificial electroreceptor (SAER) that integrates tele-perception and tactile sensation to track the rehabilitation process, collecting signals related to approaching speed and grip strength sequentially. The SAER uses polyurethane ionoelastomer incorporated with quasi-solid conductive salt as the electric field receptor, and is integrated on a rehabilitation-training ball after assembly to establish an untethered detection device; this enables the remote capture of hand approaching parameter within a 9 cm range, followed by the quantification of grip strength when contacting and grasping. Furthermore, a data-driven assessment system is established by integrating machine learning, which accurately classifies rehabilitation efficiency into six levels; it supports for rehabilitation evaluation and training programs adjustment. Overall, the SAER-based rehabilitation management system establishes a paradigm that synergistically evaluating parameters corresponding to neuromuscular functional restoration and holds strong potential for home-based active rehabilitation for minimizing dependence on frequent clinical supervision.
Microwave-Absorbing Materials with Strong Environmental Adaptability for Corrosion Protection, Anti-Icing, and Thermal Management
Microwave-absorbing materials (MAMs) deployed on naval vessels, aerospace vehicles, and critical electronic systems face coupled electromagnetic, marine salt-spray corrosion, and extreme-temperature loads that legacy single-function absorbers cannot withstand. This review consolidates progress on three environmentally adaptive MAM classes: corrosion-protective, anti-icing, and thermal-management absorbers. The electromagnetic loss and impedance-matching fundamentals are first established, then the synergistic mechanisms, design strategies, and characterization protocols for each class are examined against representative material systems and their measured performance. The analysis identifies a shared design logic—multiscale hierarchical architecture, interfacial polarization engineering, and multifunctional phase integration—while distinguishing the divergent protection mechanisms: barrier and passivation effects for corrosion, surface-energy and latent-heat regulation for anti-icing, and phonon–electron transport decoupling for thermal management. Persistent bottlenecks include the trade-off between impedance matching and protective-layer density, the absence of standardized coupled-field test protocols, and the scarcity of long-term salt-spray and thermal-cycling durability data. Future directions are delineated: intelligent self-adaptive absorbers, multiphysics-coupled simulation frameworks, and environmentally benign multifunctional integration. The review provides a theoretical and technical basis for the design, construction, and engineering scale-up of next-generation high-performance absorbers for aerospace, electronic, and marine equipment.